Aniban, Rhofe P.
HRN: 21-28-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/29/2022
05/06/2022
IV
600mg
Q8H
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes